Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pharmaceuticals

Items 1 to 10 of 3027 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 303
  1. Net price*
    Year
  2. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Mertiva AB (MERT MTF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    25 pages
    Mertiva AB (Mertiva) is a pharmaceutical company. It conducts operations through its wholly-owned subsidiary, Diamyd Medical AB. The company develops products for the treatment and prevention of autoimmune diabetes. The company’s lead drug is Diamyd (rhGAD65) and is under investigation for the treatment and prevention of type 1 diabetes
    Englisch | Zukunftsanalyse | SKU: 987673072
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Beactica AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    22 Pages
    Beactica AB (Beactica) is a biopharmaceutical company. The company develops novel therapeutics using utilizing its proprietary methodologies to evaluate the interaction of molecules. It provides services such as fragment-based lead generation yields, high-resolution kinetic data of inhibitors, extended rate analysis, and optimization of t
    Englisch | Zukunftsanalyse | SKU: 163247
  4. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Syn-Tech Chem. & Pharm. Co., Ltd. (1777) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of Syn-Tech Chem. & Pharm. Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats
    Englisch | Zukunftsanalyse | SKU: 85504
  5. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Risperdal (Schizophrenia) - Forecast and Market Analysis to 2022

    GlobalData
    44 pages
    Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning and cognitive deficits. WHO experts have
    Englisch | Zukunftsanalyse | SKU: 402549
  6. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Genexine, Inc. (095700) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    Genexine, Inc. (Genexine) is a biotechnology company. The company develops and conducts research on therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs such as super-biosimilars. Its products include GX-E2 for Anemia, GX-G6 for Diabetes, GX-H9 for Dwarfism, GX-188E (Therapeutic Vaccine) and HB-110
    Englisch | Zukunftsanalyse | SKU: 358530
  7. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Angiosarcoma Global Clinical Trials Review, H1, 2015

    GlobalData
    78 pages
    GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H1, 2015" provides data on the Angiosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Angiosarcoma. It includes an overview of the trial numbers and their recruitment status as per the si
    Englisch | Zukunftsanalyse | SKU: 987679994
  8. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    Eurofins Scientific SE (Eurofins) is an International group of laboratories, engaged in providing comprehensive range of bioanalytical testing and support services to governments and various pharmaceutical, food, environmental and consumer products industries. The company offers testing in three main areas, namely, pharmaceutical, food an
    Englisch | Zukunftsanalyse | SKU: 84884
  9. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    AstraZeneca UK Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    20 pages
    AstraZeneca UK Limited (AstraZeneca) is a pharmaceutical company. The company develops and markets medicines. Its products include exenatide prolonged-release suspension for injection, rosuvastatin, dapagliflozin, saxagliptin, atenolol, lidocaine, lisinopril dihydrate, ceftaroline fosamil, goserelin acetate, zolmitriptan, metformin hydroc
    Englisch | Zukunftsanalyse | SKU: 331430
  10. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Liver Cirrhosis Global Clinical Trials Review, H1, 2015

    GlobalData
    82 pages
    GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H1, 2015" provides an overview of Liver Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries
    Englisch | Zukunftsanalyse | SKU: 987688592
  11. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Labor And Delivery Global Clinical Trials Review, H2, 2015

    GlobalData
    315 pages
    GlobalData's clinical trial report, “Labor And Delivery Global Clinical Trials Review, H2, 2015" provides an overview of Labor And Delivery clinical trials scenario. This report provides top line data relating to the clinical trials on Labor And Delivery. Report includes an overview of trial numbers and their average enrollment in top c
    Englisch | Marktstudie | SKU: 987689527

Items 1 to 10 of 3027 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 303